SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 139,800
+700 (0.50%)
At close: Nov 28, 2025
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 10.95 trillion as of November 28, 2025. Its market cap has increased by 22.20% in one year.
Market Cap
10.95T
Enterprise Value
10.76T
Revenue
675.41B
Ranking
n/a
PE Ratio
34.16
Stock Price
139,800.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has increased from 9.95T to 10.95T, an increase of 10.08%. That is a compound annual growth rate of 1.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 10.95T | 25.83% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.19T |
| Celltrion | 40.52T |
| ALTEOGEN | 27.70T |
| ABL Bio | 9.64T |
| Yuhan | 8.91T |
| Peptron | 7.44T |
| LigaChem Biosciences | 6.58T |
| HLB Co., Ltd. | 6.09T |